Eli Lilly (LLY) Net Cash Flow (2009 - 2026)

Eli Lilly (LLY) has reported Net Cash Flow for 18 consecutive years, with -$2.1 billion the latest figure, recorded in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$2.1 billion, down 568.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 billion (up 147.01% YoY), and the FY2025 annual result was $3.6 billion, up 386.33% from the prior year.
• Net Cash Flow was -$2.1 billion for Q1 2026 at Eli Lilly, up from -$2.5 billion in the prior quarter.
• Over five years, Net Cash Flow peaked at $6.4 billion in Q3 2025 and troughed at -$2.5 billion in Q4 2025.
• Average Net Cash Flow over 5 years is $77.7 million, with a median of -$81.5 million recorded in 2024.
• Year-over-year, Net Cash Flow slumped 16689.47% in 2023 and jumped 7933.5% in 2025.
• Over 5 years, Net Cash Flow stood at -$422.2 million in 2022, then soared by 173.07% to $308.5 million in 2023, then rose by 6.13% to $327.4 million in 2024, then sank by 850.27% to -$2.5 billion in 2025, then advanced by 16.42% to -$2.1 billion in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$2.1 billion in Q1 2026, -$2.5 billion in Q4 2025, and $6.4 billion in Q3 2025.